Agenus (AGEN) Cash from Investing Activities (2010 - 2026)

Agenus' (AGEN) quarterly Cash from Investing Activities came in at $69.0 million in Q1 2026, up 120868.42% year-on-year from N/an in Q1 2025, and up 8740.0% quarter-over-quarter from $780000.0 in Q4 2025.

Agenus (AGEN) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Agenus' Cash from Investing Activities history runs 17 years deep, the most recent figure standing at $69.0 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities rose 120868.42% year-over-year to $69.0 million in Q1 2026; TTM through Mar 2026 was $70.1 million, a 48437.24% increase from a year earlier, with the FY2025 full-year figure at $1.2 million, up 4322.22% from the prior year.
  • Cash from Investing Activities grew to $69.0 million in Q1 2026 per AGEN's latest filing, from $780000.0 in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $69.0 million in Q1 2026 and bottomed at -$15.6 million in Q3 2022.
  • The 5-year median for Cash from Investing Activities is $57000.0 (2025), against an average of $2.4 million.
  • Across the five-year window, Cash from Investing Activities tumbled 3743.37% in 2022 and surged 120868.42% in 2026, its largest moves.
  • Year by year, Cash from Investing Activities stood at -$6.4 million in 2022, then surged by 144.24% to $2.8 million in 2023, then plunged by 100.74% to -$21000.0 in 2024, then surged by 3814.29% to $780000.0 in 2025, then surged by 8740.0% to $69.0 million in 2026.
  • Per Business Quant, the three latest AGEN Cash from Investing Activities figures stand at $69.0 million (Q1 2026), $780000.0 (Q4 2025), and $76000.0 (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn -45.51 Mn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn -431.90 Mn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn -428.90 Mn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn -
9 Revolution Medicines 37.35 Bn 37.35 Bn - 172.62 Mn
10 Agenus 234.10 Mn 199.10 Mn 33.74 Mn 68.95 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 68.95 Mn
Mar 31, 2026 68.95 Mn
Dec 31, 2025 780,000.00
Dec 31, 2025 780,000.00
Sep 30, 2025 76,000.00
Sep 30, 2025 76,000.00
Jun 30, 2025 281,000.00
Jun 30, 2025 281,000.00
Mar 31, 2025 57,000.00
Mar 31, 2025 57,000.00
Dec 31, 2024 -21,000.00
Dec 31, 2024 -21,000.00
Sep 30, 2024 56,000.00
Sep 30, 2024 56,000.00
Jun 30, 2024 -237,000.00
Jun 30, 2024 -237,000.00
Mar 31, 2024 229,000.00
Mar 31, 2024 229,000.00
Dec 31, 2023 2.82 Mn
Dec 31, 2023 2.82 Mn